Table 2 Graft quality upon receipt and post-thaw
n | Median | Range (IQR) | |
|---|---|---|---|
WBC | |||
Concentration (× 103/µL) | 100 | 189 | 102–581 (168–243) |
Total cell number (× 1010) | 100 | 5.74 | 1.29–16.25 (4.58–7.40) |
Cell dose (× 106/kg body weight) | 100 | 817.4 | 165.9–5772 (582.3–1091) |
Viability at receipt (%) | 100 | 99.12 | 95.04–99.78 (98.89–99.39) |
Viability after thaw (%) | 100 | 63.11 | 41.60–83.66 (56.45–67.97) |
Recovery viable WBC (%) | 100 | 36 | 21–68 (30–41) |
CD34+ | |||
Concentration (cells/µL) | 100 | 1649 | 246–10,345 (1200–2450) |
Total cell number (× 106) | 100 | 484.5 | 39.6–1298 (323.5–675.6) |
Cell dose (× 106/kg body weight) | 100 | 7.22 | 0.84–68.63 (4.78–9.51) |
Viability at receipt (%) | 100 | 99.61 | 92.33–100 (99.15–99.85) |
Viability after thaw (%) | 100 | 94.41 | 69.87–98.43 (90.77–95.94) |
Recovery viable CD34+ (%) | 100 | 42.20 | 23.20–92.40 (36.33–48.65) |
Cell dose after thaw (× 106/kg body weight) | 100 | 2.81 | 0.39–29.60 (1.77–3.95) |